| Jul 10 |
Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
|
| Jul 5 |
Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
|
| Jun 19 |
How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43%
|
| Jun 10 |
Exscientia: Too Much Pessimism
|
| Jun 6 |
Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology
|
| Jun 3 |
Can Exscientia (EXAI) Climb 57.17% to Reach the Level Wall Street Analysts Expect?
|
| May 30 |
Exscientia to Present at Upcoming Investor Conferences in June
|
| May 25 |
Analysts Are Upgrading Exscientia plc (NASDAQ:EXAI) After Its Latest Results
|
| May 24 |
Exscientia plc (EXAI) Q1 2024 Earnings Call Transcript
|
| May 23 |
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
|
